PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791482
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791482
Global Artemisinic Acid Market to Reach US$847.8 Million by 2030
The global market for Artemisinic Acid estimated at US$717.1 Million in the year 2024, is expected to reach US$847.8 Million by 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Antimalarial Injections Application, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$445.6 Million by the end of the analysis period. Growth in the Antimalarial Tablets Application segment is estimated at 2.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$195.4 Million While China is Forecast to Grow at 5.5% CAGR
The Artemisinic Acid market in the U.S. is estimated at US$195.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$166.2 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.
Global Artemisinic Acid Market - Key Trends & Drivers Summarized
Why Is Artemisinic Acid Crucial in Pharmaceuticals?
Artemisinic acid is a vital precursor in the production of artemisinin, an essential compound for antimalarial drugs. Its role in combating malaria, a major global health concern, underscores its importance in the pharmaceutical industry. The acid is also gaining attention for its potential applications in treating other diseases, including certain cancers and viral infections. Innovations in synthetic biology have enabled the production of artemisinic acid using genetically engineered yeast strains, ensuring a more sustainable and scalable supply chain compared to traditional extraction from Artemisia annua plants.
How Is Technology Improving Production Efficiency?
Advancements in biotechnology are revolutionizing the production of artemisinic acid. Fermentation-based methods using engineered microorganisms have reduced dependence on agricultural sources, ensuring year-round availability. These methods are also more cost-effective and environmentally friendly, as they require fewer resources and produce less waste. Additionally, research into optimizing metabolic pathways has enhanced yield and purity, addressing the growing demand for artemisinin-based combination therapies (ACTs). Such innovations are critical in scaling production to meet global health needs.
Why Is Artemisinic Acid Gaining Broader Applications?
Beyond malaria treatment, artemisinic acid is being explored for its potential in developing novel therapies for diseases such as cancer, diabetes, and inflammatory conditions. Its derivatives exhibit anti-inflammatory, antitumor, and antiviral properties, broadening its appeal in medical research. The ongoing COVID-19 pandemic has further highlighted the importance of artemisinic acid in developing antiviral treatments. As pharmaceutical companies invest in expanding its applications, the market for artemisinic acid is poised for significant growth.
What Drives the Growth of the Artemisinic Acid Market?
The growth in the artemisinic acid market is driven by the increasing prevalence of malaria and the rising need for antimalarial drugs in developing regions. Innovations in synthetic biology and fermentation technologies have reduced production costs, enhancing affordability for resource-constrained healthcare systems. The exploration of its broader therapeutic applications is attracting significant investment from pharmaceutical companies. Government initiatives and funding for malaria eradication programs further support market growth. Additionally, the expanding research into its potential as a bioactive compound in oncology and virology underscores its growing importance in global healthcare.
SCOPE OF STUDY:
The report analyzes the Artemisinic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Application (Antimalarial Injections Application, Antimalarial Tablets Application)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 32 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.